United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 28, 2026 · Filed Sep 29, 2026

On Sep 28, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$480.85 for US$4.57M under a trading plan, leaving 324,443 shares. Filed Sep 29, 2026 (Form 4).

Sold
9,500 shares
Price
US$480.85 average (US$472.43 to US$486.01)
Value
US$4.57M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 28, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 28, 2026Common StockSale280US$472.43333,663Indirect
Sep 28, 2026Common StockSale600US$473.28333,063Indirect
Sep 28, 2026Common StockSale680US$474.46332,383Indirect
Sep 28, 2026Common StockSale80US$475.28332,303Indirect
Sep 28, 2026Common StockSale160US$476.68332,143Indirect
Sep 28, 2026Common StockSale200US$477.45331,943Indirect
Sep 28, 2026Common StockSale601US$479.06331,342Indirect
Sep 28, 2026Common StockSale1,013US$480.18330,329Indirect
Sep 28, 2026Common StockSale1,354US$481.20328,975Indirect
Sep 28, 2026Common StockSale693US$482.11328,282Indirect
Sep 28, 2026Common StockSale1,539US$483.20326,743Indirect
Sep 28, 2026Common StockSale825US$484.47325,918Indirect
Sep 28, 2026Common StockSale1,315US$485.45324,603Indirect
Sep 28, 2026Common StockSale160US$486.01324,443Indirect

Source

View original at SEC

Related